You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antagonist administration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Female Infertility Trial in Alexandria (Growth Hormone)

Completed
  • Female Infertility
  • Growth Hormone
  • Alexandria, Egypt
    faculty of medicine, Alexandria University
Aug 8, 2022

HIV-1-infection Trial in Aarhus (Venetoclax)

Not yet recruiting
  • HIV-1-infection
  • Aarhus, Denmark
    Aarhus University Hospital
Jan 5, 2023

Kidney Transplantation Trial in Nantes (FR104)

Recruiting
  • Kidney Transplantation
  • Nantes, France
    Blancho
Mar 24, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Hereditary Angioedema Trial in Worldwide (CSL312, Placebo)

Completed
  • Hereditary Angioedema
  • CSL312
  • Placebo
  • Birmingham, Alabama
  • +27 more
Aug 2, 2022

Ovarian Hyperstimulation Syndrome Trial in Cairo (Gonadotropin, Antagonist)

Completed
  • Ovarian Hyperstimulation Syndrome
  • Cairo, Egypt
  • +1 more
Nov 20, 2019

Diminished Ovarian Reserve Trial (Dydrogesterone priming ovarian stiumulation protocol, GnRH antagonist protocol)

Not yet recruiting
  • Diminished Ovarian Reserve
  • Dydrogesterone priming ovarian stiumulation protocol
  • GnRH antagonist protocol
  • (no location specified)
Apr 26, 2023

PONV in Laparoscopic Cholocystectomies Trial in Larissa (Dimenhydrinate Tablets, Ondansetron iv)

Completed
  • PONV in Laparoscopic Cholocystectomies
  • Dimenhydrinate Tablets
  • Ondansetron iv
  • Larissa, Thessaly, Greece
    University Hospital of Larisa, Department of Anesthesiology
Dec 7, 2022

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Healthy Trial in London (teverelix TFA)

Completed
  • Healthy
  • teverelix TFA
  • London, Middlesex, United Kingdom
    PAREXEL International Early Phase Clinical Unit (EPCU)
Mar 16, 2020

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Polycystic Ovary Syndrome Trial (Ganirelix)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • (no location specified)
Feb 20, 2023

Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)

Not yet recruiting
  • Magnesium
  • Intraoperative Analgesia
  • (no location specified)
Nov 12, 2023

IVF, Ovarian Cysts Trial in Be'er Ya'aqov (Cetrorelix Acetate, Ganerelix Acetate)

Recruiting
  • IVF
  • Ovarian Cysts
  • Cetrorelix Acetate, Ganerelix Acetate
  • Be'er Ya'aqov, Israel
    Shamir Medical center
Oct 5, 2021

Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])

Completed
  • Gastric Cancer
  • +2 more
  • Ramucirumab Injection
  • Ramucirumab Injection [Cyramza]
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting
  • Depressive Disorder, Major
  • Anxiety Disorder
  • Nociceptin Receptor Antagonist
  • Aversive stimuli
  • (no location specified)
Nov 3, 2022

IVF Trial in Be'er Ya'aqov (Ganirelix Acetate, Cetrolix Acetate)

Recruiting
  • IVF
  • Ganirelix Acetate, Cetrolix Acetate
  • Be'er Ya'aqov, Israel
    Shamir Medical center
Oct 5, 2021

Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)

Completed
  • Healthy
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Jan 12, 2023

Fertility Trial in Barcelona (150µg CFA (Elonva®) at stimulation day (SD) 1 and 100µg CFA(Elonva®) at SD 5, 150µg CFA (Elonva®)

Not yet recruiting
  • Fertility
  • 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5
  • 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
  • Barcelona, Spain
    Hospital Universitario Quiron Dexeus
Nov 10, 2023

COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)

Recruiting
  • COVID-19
  • Hospitalized COVID-19 Patients
  • Lopinavir / Ritonavir
  • +3 more
  • Zgharta, North, Lebanon
  • +1 more
Jun 28, 2023

Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

Not yet recruiting
  • Depressive Disorder
  • +4 more
  • Perampanel 6 MG
  • +2 more
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Mar 14, 2023

Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-exacerbated Respiratory Disease Trial in Boston (Ifetroban, Placebo)

Active, not recruiting
  • Nasal Polyps
  • +3 more
  • Boston, Massachusetts
    Asthma Research Center, Brigham and Women's Hospital
Oct 7, 2022

Pancreas Cancer Trial in New York, Cambridge (Plerixafor)

Terminated
  • Pancreas Cancer
  • New York, New York
  • +1 more
Feb 27, 2020

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • CXCR4 Antagonist BL-8040
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022